New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2014
07:09 EDTALIMAlimera Sciences resubmits NDA for Iluvien
Alimera Sciences has resubmitted its New Drug Application for Iluvien to the FDA. At this time, Alimera awaits the FDA's acceptance of the resubmission and a Prescription Drug User Fee Act date.
News For ALIM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 23, 2015
07:10 EDTALIMAlimera Sciences to host analyst/investor meeting
Analyst/Investor Meeting to be held in New York on March 25 at 12:15 pm. Webcast Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use